CAPILLARY - Capillary Tech.
Financial Performance
Revenue Growth by Segment
Not disclosed in available documents.
Geographic Revenue Split
Not disclosed in available documents.
Profitability Margins
Not disclosed in available documents.
EBITDA Margin
Not disclosed in available documents.
Capital Expenditure
Not disclosed in available documents.
Credit Rating & Borrowing
Not disclosed in available documents.
Operational Drivers
Raw Materials
Not disclosed in available documents.
Import Sources
Not disclosed in available documents.
Key Suppliers
Not disclosed in available documents.
Capacity Expansion
Not disclosed in available documents.
Raw Material Costs
Not disclosed in available documents.
Manufacturing Efficiency
Not disclosed in available documents.
Logistics & Distribution
Not disclosed in available documents.
Strategic Growth
Expected Growth Rate
Not disclosed in available documents.
Growth Strategy
The company is focusing on human capital retention and alignment through the ratification of the Capillary Employees Stock Option Scheme-2021 (ESOP 2021). This strategy is intended to incentivize employees by linking compensation to company performance, which is critical for maintaining a competitive edge in the technology sector.
Products & Services
Not disclosed in available documents.
Brand Portfolio
Capillary
New Products/Services
Not disclosed in available documents.
Market Expansion
Not disclosed in available documents.
Market Share & Ranking
Not disclosed in available documents.
Strategic Alliances
Not disclosed in available documents.
External Factors
Industry Trends
The technology industry is seeing a trend of increased shareholder activism and institutional scrutiny regarding executive and employee compensation. This is evidenced by the 49.7440% of institutional votes (5,947,972 votes) cast against the ratification of the ESOP 2021 scheme, indicating a significant divide in investor expectations regarding dilution and incentive structures.
Competitive Landscape
Not disclosed in available documents.
Competitive Moat
Not disclosed in available documents.
Macro Economic Sensitivity
Not disclosed in available documents.
Consumer Behavior
Not disclosed in available documents.
Geopolitical Risks
Not disclosed in available documents.
Regulatory & Governance
Industry Regulations
The company operates under the regulatory oversight of SEBI, specifically complying with Regulation 44(3) of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, and Section 108 of the Companies Act, 2013, regarding the conduct of postal ballots and electronic voting for special resolutions.
Environmental Compliance
Not disclosed in available documents.
Taxation Policy Impact
Not disclosed in available documents.
Legal Contingencies
Not disclosed in available documents.
Risk Analysis
Key Uncertainties
A key business risk is the high level of institutional investor dissent, with 49.7440% of institutional votes opposing the ESOP 2021 ratification. This lack of consensus could lead to future friction regarding corporate governance and capital allocation strategies. The resolution passed primarily due to 100% support from the Promoter and Promoter Group (41,195,648 votes).
Geographic Concentration Risk
Not disclosed in available documents.
Third Party Dependencies
Not disclosed in available documents.
Technology Obsolescence Risk
Not disclosed in available documents.
Credit & Counterparty Risk
Not disclosed in available documents.